chr16-28903037-G-A
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3_Moderate
The NM_004320.6(ATP2A1):c.2752G>A(p.Glu918Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,613,558 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004320.6 missense
Scores
Clinical Significance
Conservation
Publications
- Brody myopathyInheritance: AR, AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004320.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATP2A1 | NM_004320.6 | MANE Select | c.2752G>A | p.Glu918Lys | missense | Exon 20 of 23 | NP_004311.1 | ||
| ATP2A1 | NM_173201.5 | c.2752G>A | p.Glu918Lys | missense | Exon 20 of 22 | NP_775293.1 | |||
| ATP2A1 | NM_001286075.2 | c.2377G>A | p.Glu793Lys | missense | Exon 18 of 21 | NP_001273004.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ATP2A1 | ENST00000395503.9 | TSL:1 MANE Select | c.2752G>A | p.Glu918Lys | missense | Exon 20 of 23 | ENSP00000378879.5 | ||
| ATP2A1 | ENST00000357084.7 | TSL:2 | c.2752G>A | p.Glu918Lys | missense | Exon 20 of 22 | ENSP00000349595.3 | ||
| ATP2A1 | ENST00000536376.5 | TSL:2 | c.2377G>A | p.Glu793Lys | missense | Exon 18 of 21 | ENSP00000443101.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 151952Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.00000796 AC: 2AN: 251242 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461606Hom.: 0 Cov.: 35 AF XY: 0.00000275 AC XY: 2AN XY: 727118 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151952Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 74202 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Uncertain:1
Brody myopathy Uncertain:1
This sequence change replaces glutamic acid with lysine at codon 918 of the ATP2A1 protein (p.Glu918Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is present in population databases (rs376101862, ExAC 0.01%). This variant has not been reported in the literature in individuals affected with ATP2A1-related conditions. ClinVar contains an entry for this variant (Variation ID: 446881). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at